Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04817969 · ClinicalTrials.gov registry record · NA

Persona Ti-Nidium Post-Market Clinical Follow-up

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
240
Enrollment target
7
Study locations

NCT04817969 is a NA study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 240 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04817969, a NA study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
7
Study locations

Study Summary

The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

Interventions

  • DEVICE Zimmer Biomet Persona Ti-Nidium Total Knee System

Study Locations (7)

Colorado

  • Denver Hip & Knee, Inc. - Parker

Maryland

  • MedStar Health Research Institute - Hyattsville

Mississippi

  • Mississippi Sports Medicine and Orthopaedic Center - Jackson

New Mexico

  • New Mexico Orthopaedic Associates - Albuquerque

North Carolina

  • Duke University - Durham

Pennsylvania

  • Rothman Orthopaedic Institute - Philadelphia

South Dakota

  • Monument Health Rapid City Hospital, Inc. - Rapid City

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2021-06-01
Est. Completion 2034-05
Phase NA

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT04817969

The ClinicalTrials.gov registry entry for NCT04817969 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Zimmer Biomet Persona Ti-Nidium Total Knee System is the first listed.

NCT04817969 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Colorado, Maryland, Mississippi.

Frequently Asked Questions

What is clinical trial NCT04817969 about?

NCT04817969 is a clinical study titled "Persona Ti-Nidium Post-Market Clinical Follow-up". The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

What is the current status of trial NCT04817969?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2021-06-01. Estimated completion is 2034-05.

What conditions does trial NCT04817969 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Knee Pain Chronic, Traumatic Arthritis.

What interventions are being tested in trial NCT04817969?

The interventions under investigation include: Zimmer Biomet Persona Ti-Nidium Total Knee System (DEVICE).

Who is sponsoring clinical trial NCT04817969?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04817969 being conducted?

This trial has 7 study locations across Colorado, Maryland, Mississippi, New Mexico, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.